Skip to main content
. 2017 Sep 26;6:25. doi: 10.1186/s40035-017-0096-2

Fig. 1.

Fig. 1

The conceptual framework for disease-modification in neurodegenerative disorders included neuroprotection preventing neurodegeneration with biomarker and clinical support for a disease-modifying therapy (DMT)